| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/1997 | DE19600357C1 DNA-Sequenz kodierend einen Phosphoenolpyruvat-Phosphat-Translokator, Plasmide, Bakterien, Hefen und Pflanzen enthaltend diesen Transporter DNA sequence encoding a phosphoenolpyruvate-phosphate translocator, plasmids, bacteria, yeasts and plants containing these transporters |
| 02/13/1997 | DE19529696A1 Transgene Pflanzenzellen und Pflanzen mit gesteigerter Glykolyserate Transgenic plant cells and plants with increased glycolysis |
| 02/13/1997 | CA2228727A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | CA2228712A1 Nucleic acid detection method using nucleotide probes enabling both specific capture and detection |
| 02/13/1997 | CA2228378A1 Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 02/13/1997 | CA2228374A1 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2227989A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227871A1 Mucosal delivery of polynucleotides |
| 02/13/1997 | CA2227844A1 Herpes simplex virus diagnostics |
| 02/13/1997 | CA2227786A1 Transport proteins and their uses |
| 02/13/1997 | CA2227770A1 Improvements in or relating to delivery of nucleic acid |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227599A1 Broad specificity antibodies |
| 02/13/1997 | CA2227369A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | CA2227328A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | CA2227007A1 Transgenic "knock out" mice expressing a human apolipoprotein e |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2224907A1 Methods and means for targeted gene delivery |
| 02/13/1997 | CA2224492A1 A method of and test kit for mutagenesis testing |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0758020A2 The use of homologous amdS genes as selectable markers |
| 02/12/1997 | EP0758019A1 A process for the preparation of replicators |
| 02/12/1997 | EP0757994A1 Tcf mutant |
| 02/12/1997 | EP0757722A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
| 02/12/1997 | EP0757721A1 Regulatory element conferring tapetum specificity |
| 02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0757696A1 Human sperm diagnostic |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0675969B1 Method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction |
| 02/12/1997 | EP0604552B1 Method of synthesizing diverse collections of oligomers |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142856A Process for producing L-Lysine by fermentation |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142853A Gene for fatty acid desaturase, vector containing said gene, plant containing said gene transferred thereinto, and process for creating said plant |
| 02/12/1997 | CN1142852A The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process |
| 02/12/1997 | CN1142829A Compounds and methods for site-directed mutations in eukaryotic cells |
| 02/12/1997 | CN1142775A Preparation and use of immunoconjugates |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142538A Two carriers based on pBV220 carrier |
| 02/12/1997 | CN1142537A Life body induction and transformation gene engineering material, carrier and marking protein |
| 02/12/1997 | CN1142536A Bacillus-derived transglutaminase |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CN1142502A Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli |
| 02/11/1997 | USRE35450 Immunosuppressants, antiinflammatory agents |
| 02/11/1997 | US5602756 Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
| 02/11/1997 | US5602322 Constitutitive triple response gene and mutations |
| 02/11/1997 | US5602321 Transgenic cotton plants producing heterologous polyhydroxy(e) butyrate bioplastic |
| 02/11/1997 | US5602309 For study of neurodegenerative disorders, i.e. parkinson's and alzheimer's diseases |
| 02/11/1997 | US5602307 Non-human animal having predefined allele of a cellular adhesion gene |
| 02/11/1997 | US5602306 Transgenic pig expressing human hemoglobin |
| 02/11/1997 | US5602304 Hairless mouse |
| 02/11/1997 | US5602301 Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
| 02/11/1997 | US5602300 Isolating dna from cells of transgenic mammal, fragmenting dna with restriction enzyme, contacting fragmented dna with solid particles to which a lacz operator binding material is bound, separating from non-bound dna |
| 02/11/1997 | US5602299 Express human neurofilament subunit gene, exhibit brain neurofibrillary tangles and pick-like bodies |
| 02/11/1997 | US5602243 For amplification of a deleted in colorectal cancer gene by polymerase chain reaction |
| 02/11/1997 | US5602242 Genetic engineered, encapsidated protein shell transfecting the plant cells |
| 02/11/1997 | US5602102 Dipeptidyl peptidase-I inhibitors and uses thereof |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602034 Genetic engineering |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602030 recombinant host bacterium that contains a pathway for glucose uptake other than the pathway normally utilized by the host cell; by uncoupling glucose transport into the cell from PEP utilization, more PEP is produced for synthesis of products of commercial importance from a given quantity of biomass |
| 02/11/1997 | US5602027 Cell line TriH8 obtained by the fusion of the human epidermoid carcinoma cell line A431 with the TOS/H8 hybridoma |
| 02/11/1997 | US5602025 Growth in serum-free media |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602021 Identifying wild-type protease capable of cleaving polypeptide homologous to target, introducing into host cells phage system containing phage encoding mutants and phage encoding gene product necessary for infection, culturing |
| 02/11/1997 | US5602020 Genetic engineering; cloning from vibrio parahemolyticus |
| 02/11/1997 | US5602019 Genetic engineering |
| 02/11/1997 | US5602018 Having uniform low glycosylation, improved thermal stability |
| 02/11/1997 | US5602017 Cholesterol oxidase |
| 02/11/1997 | US5602016 D-amino acid oxidase from F. solani and DNA therefor |
| 02/11/1997 | US5602014 Genetic engineering; hydrolyzing acrylonitrile with transformed microorganism of genus rhodococcus to produce acrylic acid |
| 02/11/1997 | US5602011 Purified Thermococcus barossii DNA polymerase |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602008 Genetic engineering |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5602006 Heteropolymeric protein production methods |
| 02/11/1997 | US5602004 Genetic engineering |
| 02/11/1997 | US5602003 N-acetylglucosaminyltransferase V gene |
| 02/11/1997 | US5602001 Cell-free method for synthesizing a protein |
| 02/11/1997 | US5602000 Method for enzymatic synthesis of oligonucleotides |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601978 Oligonucleotides and methods for the detection of chlamydia trachomatis |
| 02/11/1997 | US5601974 Method of detecting viral infection in vaccinated animals |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601828 CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601823 Avian antitoxins to clostridium difficle toxin A |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |